THE ROLE OF PLATELET FACTOR 4 IN RADIATION-INDUCED THROMBOCYTOPENIALAMBERT, Michele P; LIQING XIAO; NGUYEN, Yvonne et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 5, pp 1533-1540, issn 0360-3016, 8 p.Article

Chemokines and thrombogenicity : Chemokines in vascular biologyLAMBERT, Michele P; SACHAIS, Bruce S; KOWALSKA, M. Anna et al.Thrombosis and haemostasis. 2007, Vol 97, Num 5, pp 722-729, issn 0340-6245, 8 p.Article

A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemiaLAMBERT, Michele P; JING JIANG; BATRA, Vandana et al.American journal of hematology. 2012, Vol 87, Num 5, pp 532-534, issn 0361-8609, 3 p.Article

Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor―related protein 1 (LRP1) on megakaryocytesLAMBERT, Michele P; YUHUAN WANG; BDEIR, Khalil H et al.Blood. 2009, Vol 114, Num 11, pp 2290-2298, issn 0006-4971, 9 p.Article

The Incidence of Thrombocytopenia in Children With Cornelia de Lange SyndromeLAMBERT, Michele P; JACKSON, Laird G; CLARK, Dinah et al.American journal of medical genetics. Part A. 2011, Vol 155, Num 1, pp 33-37, issn 1552-4825, 5 p.Article

RhIG for the treatment of immune thrombocytopenia: consensus and controversyDESPOTOVIC, Jenny M; LAMBERT, Michele P; HERMAN, Jay H et al.Transfusion (Philadelphia, PA). 2012, Vol 52, Num 5, pp 1126-1136, issn 0041-1132, 11 p.Article

Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis : Clinical and therapeutic implications. CommentaryLEAVITT, Andrew D; LAMBERT, Michele P; RAUOVA, Lubica et al.Blood. 2007, Vol 110, Num 4, issn 0006-4971, 1090, 1153-1160 [9 p.]Article